Section Arrow
ZBH.NYSE
- Zimmer Biomet Holdings
Quotes are at least 15-min delayed:2025/01/21 05:21 EST
Last
 109.56
+0.62 (+0.57%)
Day High 
109.97 
Prev. Close
108.94 
1-M High
110.45 
Volume 
1.10M 
Bid
100.53
Ask
110.3
Day Low
108.4723 
Open
108.99 
1-M Low
100.668 
Market Cap 
21.69B 
Currency USD 
P/E 20.79 
%Yield 0.88 
10-SMA 104.74 
20-SMA 105.67 
50-SMA 108.01 
52-W High 133.9 
52-W Low 100.668 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
5.24/9.19
Enterprise Value
26.55B
Balance Sheet
Book Value Per Share
62.16
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
7.39B
Operating Revenue Per Share
36.57
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed:2025/01/21 05:21 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.